Board of Directors

 tony_evans

Dr Tony Evans,
PhD, MAICD
Chairman

Dr Evans has more than 25 years of senior management experience in research and biotechnology business and corporate development.
 
More

 WT_100

Dr Warwick Tong,
MB, ChB, MPP, GAICD
CEO

Dr Tong brings more than 19 years experience of senior leadership in medical, clinical, commercial and business development in the major pharmaceutical and biotechnology sectors.

More
 
George_Morstyn_100

Dr George Morstyn,
MB, BS, BMed Sci, PhD, FRACP, MAICD

Dr Morstyn has extensive experience in drug development and biotechnology. He was head of the clinical program at the Ludwig Institute for Cancer Research in Melbourne and Principal Investigator on the earliest clinical studies of haemopoietic growth factors.

More
 deborah_rathjen

Dr Deborah Rathjen,
PhD, FTSE, MAICD

Dr Rathjen has significant experience in research, business development and licensing, and specific expertise in inflammation and cancer. She is CEO & Managing Director of Bionomics, having joined the Company from Peptech Limited, where she was Manager of Business Development and Licensing.

More

Katherine_Woodthorpe_1001 (1)

Dr Katherine Woodthorpe,
PhD, FAICD

Dr Katherine Woodthorpe has been cited in various media as one of Australia’s most influential people in innovation and has a strong track record in commercialization. She is currently the Chair of the Antarctic Climate and Ecosystems CRC and was Chief Executive of AVCAL, the Australian Private Equity and Venture Capital Association for seven years.

More

NG_100

A\Professor Nicholas Gough,
PhD, FTSE, MAICD

Over 35 years experience in academic biomedical research and cancer biology, in the biotechnology industry, and in the Cooperative Research Centres program.

More

 
Ian_McDonald_100px

Dr Ian McDonald,
PhD

Dr McDonald has more than 25 years international experience in managing drug discovery and design teams in Australia, Europe and the USA.

More